Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Electric pulses may ease walking for kids with cerebral palsy

NCT ID NCT06811545

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 20, 2026 · Updated 2 times

Summary

This study tests if gentle electrical stimulation to leg muscles can help children with cerebral palsy walk more easily. About 65 children (ages 7-18) will walk on a treadmill while different stimulation settings are compared. The goal is to find which method works best to improve their walking pattern.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 65 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

\*Inclusion Criteria\* CP Group: * Age 7-18 * Diagnosis of spastic diplegic cerebral palsy (CP) * GMFCS level I-III (be able to walk with or without assistive devices) * MIGR \< 40% femoral head covering in acetabulum * Crouch, equinus, or jump gait * At least 0° passive dorsiflexion range of motion (ROM) * Sufficient visuoperceptual, cognitive, and communication skills * Seizure-free or well-controlled seizures * No other neurological or musculoskeletal disorders (e.g. dystonia, severe scoliosis, hip instability * Ability to travel to the University of Nebraska at Omaha two times * Ability to communicate pain or discomfort * Ability to obtain child assent and obtain parent/guardian consent Healthy adults (control) group: * Adults aged 20 to 40 * Adults with good physical health * Adults with the ability to follow verbal instructions * Adults with the ability to walk on a treadmill for 15 minutes * No orthopedic surgery on the lower limb within the past 3 months \*Exclusion Criteria\* CP Group: * Diagnosis of athetoid or ataxic cerebral palsy (CP) * Scoliosis with primary curve \> 49% * Spinal fusions extending into the pelvis * Lower Extremity (LE) joint instability or dislocation * Severe tactile hypersensitivity * LE botulinum injections in the past 6 mo * Implanted medical device contraindicative of functional electrical stimulation (FES) * Pregnancy * Severe LE spasticity (Modified Ashworth Scale score of 4 or greater) * History of pulmonary disease limiting exercise tolerance (Asthma Control Test screen) * History of cardiac disease (American Heart Association, AH,) screen) * Excessive LE joint pain during walking * Severely limited range of joint motion/ irreversible muscle contractures, i.e.\> 10° knee flexion, \>15° hip flexion contractures, or \>5° plantarflexion contractures * LE surgery or significant injury within 1 yr. Healthy adults (control) group: * Adults with any chronic illnesses or medical conditions that could impact their health. * Adults with significant behavioral or emotional issues that could indicate developmental disorders or psychological conditions. * Adults with diagnosed developmental disorders (e.g., autism, ADHD, learning disabilities) * Adults with surgery on their lower limb within the past 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy children are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Nebraska at Omaha, Biomechanics Research Building

    Omaha, Nebraska, 68182, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.